Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
Aehr Test Systems (AEHR) – Form 4 insider filing
On 07/11/2025, President & CEO Gayn Erickson reported an automatic share withholding related to the vesting of restricted stock units (Transaction Code F). A total of 1,052 common shares were surrendered at $14.11 solely to cover tax-withholding obligations; no open-market sale occurred.
Following the transaction, Erickson’s ownership stands at 277,029 shares held directly and 291,088 shares held indirectly through a trust. The filing reiterates that the reported figure includes unvested RSUs and restricted shares.
Because the event is tax-related and involves a small fraction of the executive’s total holdings, it is viewed as neutral from a market-impact perspective.
On 07/11/2025, Aehr Test Systems (AEHR) filed a Form 4 detailing a routine Code F transaction by Vice President Alistair N. Sporck. The company withheld 312 common shares at an implied price of $14.11 to satisfy tax obligations triggered by the vesting of restricted stock units (RSUs); no open-market sale occurred. After the withholding, Sporck’s direct ownership totals 33,808 shares, with an additional 3,993 shares held indirectly through a trust. The total includes unvested RSUs, and no derivative securities were involved. Because the activity is purely administrative and does not alter the insider’s investment exposure, the filing is viewed as neutral for investors.
Aehr Test Systems (AEHR) filed a Form 4 disclosing that President & CEO Gayn Erickson had 2,489 common shares withheld on 07/11/2025 (transaction code F) at a price of $14.11 per share. The shares were automatically withheld by the issuer to cover statutory tax obligations triggered by the vesting of previously granted equity awards; no open-market sale occurred. After the withholding, Erickson retains 278,081 shares held directly and 291,088 shares held indirectly through a trust. The reported withholding represents less than 1 % of the executive’s aggregate beneficial ownership and does not signal a discretionary reduction in exposure to AEHR stock.
On July 11, 2025, Aehr Test Systems (ticker AEHR) Chief Operating Officer Adil Engineer filed a Form 4 reporting an administrative share disposition. The filing shows a Transaction Code "F," signifying that 580 common shares were automatically withheld at $14.11 each to cover tax obligations arising from the vesting of restricted stock units (RSUs). The aggregate value is roughly $8.2 thousand.
After the withholding, the executive continues to directly own 47,167 common shares, which includes unvested RSUs (as noted in footnote 2). No derivative securities were acquired or disposed of, and there were no open-market sales. Because the transaction is non-discretionary and involves a small share count relative to the officer’s total holdings, it is viewed as neutral in terms of market impact.
Aehr Test Systems (AEHR) Form 4 Filing Overview
Director Fariba Danesh reported the receipt of 9,253 shares of AEHR common stock on July 2, 2025 under a restricted stock unit (RSU) award, coded “A” for acquisition at a price of $0. After the grant, Danesh directly owns 25,643 shares, a total that includes unvested RSUs. The award vests in equal one-eighth installments every three months, contingent upon continued service on the board. No derivative securities were exercised or disposed of, and no open-market transactions occurred.
The filing appears to be part of routine director compensation rather than a discretionary purchase or sale. As such, it does not signal a material shift in ownership structure or insider sentiment, but it does modestly increase the director’s equity alignment with shareholders.